Open label, Multicenter, Prospective Study to Characterize the Pharmacokinetics and Pharmacodynamics of Cufence (Trientine Dihydrochloride) and to Investigate the Efficacy and Safety in Wilson’s Disease Patients
This research is focused on Cufence, a medicine used for Wilson's Disease. The main goals are to understand how the body absorbs, uses, and gets rid of Cufence, and to see how effective and safe it is for patients. We'll be looking closely at levels of the medicine in the blood, as well as several markers for copper levels, which are important in Wilson's Disease. We'll also be monitoring for any side effects and how the medicine affects symptoms of the condition, including liver, brain, and mental health changes. This study aims to provide more information about how Cufence works in a real-world setting.
Överblick
Vad handlar denna studie om?
This study is about a medicine called Cufence, which is already used to treat Wilson's Disease. Wilson's Disease is a rare genetic condition where too much copper builds up in the body, which can damage organs like the liver, brain, and eyes. Because Cufence is already approved and in use, this study is a 'Phase IV' study. This means we're looking to gather more information about how it works in everyday clinical practice, rather than testing if it's safe and effective for the very first time.
The main aim is to understand how your body handles Cufence. This includes how much of the medicine gets into your blood, how long it stays there, and how your body processes it. We'll also be checking various copper levels in your body, as these are key to monitoring Wilson's Disease. These checks will help us see how well Cufence is controlling the copper build-up. We'll also be keeping a close eye on any side effects you might experience.
Beyond understanding the medicine's behaviour and safety, the study will also look at how Cufence affects your health. This includes assessing any changes in your liver health, how your thinking and memory might be, and any changes in your mood or mental well-being. By collecting all this information, doctors can get a better picture of how Cufence helps people with Wilson's Disease in their daily lives.
Viktiga punkter
- The study investigates Cufence, a medicine for Wilson's Disease.
- It aims to understand how the body handles Cufence and its effectiveness.
- Safety and side effects will be closely monitored.
- It's for adults (18 years and older) with Wilson's Disease, both men and women.
- Participation involves taking Cufence and attending regular check-ups and tests.
Vem kan vara berättigad?
To be able to take part in this study, you need to have Wilson's Disease. There's no upper age limit, meaning that adults of any age are welcome to participate, as long as they are at least 18 years old.
Both men and women can join this study. If you think you might be eligible, it's always best to discuss it with your doctor or the study team.
Kan denna studie passa dig?
Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.
- Är du 18 år eller äldre?
- Do you have Wilson's Disease?
- Kan du delta i regelbundna klinikbesök?
- Are you willing to take Cufence capsules as part of the study?
Vad innebär deltagande?
If you join this study, you will be taking Cufence 200 mg capsules. You'll have regular visits to the study clinic, where doctors and nurses will check your health. They will take blood samples to measure the levels of Cufence in your body and to check your copper levels and liver function. You might also have urine tests to check copper levels.
There will be assessments to check your brain function, memory, and mood, using various questionnaires and tests. Your liver health might also be monitored using scans like Fibroscan, and other blood tests. The study will continue for a certain period, and you'll have follow-up visits after you finish taking the study medicine to make sure you're well. The total duration of your participation will be explained to you by the study team.
Potentiella risker och fördelar
Platser (4)
- —ObekräftadTyskland
- —ObekräftadFrankrike
- —ObekräftadDanmark
- —ObekräftadPolen
Vanliga frågor
What is Wilson's Disease?
Wilson's Disease is a rare inherited condition where too much copper builds up in the body, which can cause damage to organs like the liver and brain.
What is Cufence?
Cufence is a medicine that helps remove the extra copper from the body in people with Wilson's Disease.
Varför görs denna studie?
This study aims to learn more about how Cufence works in people with Wilson's Disease, including how the body uses it and how safe and effective it is in a real-world setting.
Will I get Cufence if I join?
Yes, if you join this study, you will be given Cufence 200 mg capsules as part of the research.
Kan jag sluta delta i studien när som helst?
Yes, you have the right to leave the study at any point, and your decision will not affect your future medical care.
Hur du får reda på mer
Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.
Intresserad av att delta?
Diskussion
Gemenskapsdiskussion
Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.